AGP Executive Report
Last update: 10 hours agoClinical AI Partnership: Evinova and Merck KGaA (Darmstadt) announced a multi-year collaboration to bring Evinova’s AI-native platform into Merck’s end-to-end clinical development workflow, aiming to cut study design, documentation, and operational bottlenecks. Cancer Risk Genetics: A Cambridge-led study in Nature reports direct links between inherited genes and cancer risk, suggesting future screening and treatment may need to factor in genetic background and population diversity. Infant Hemangioma Treatment: A Bayesian network meta-analysis finds oral propranolol remains the standard for infantile hemangioma, with no active therapy outperforming it and corticosteroids tied to higher adverse events. Drug Regulation Milestone: The CHMP backed the first CETP inhibitor after decades of failed attempts, with two obicetrapib-based options (alone and with ezetimibe) moving toward European review. Healthcare Litigation: A German court will hear a claim over state failures in the 2015 Germanwings crash, with plaintiffs seeking damages over pilot fitness monitoring. Smart Farming for Health: 1NCE and Pessl Instruments rolled out a METOS weather network using IoT connectivity to improve irrigation and fertilizer decisions and reduce crop disease risk.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.